PLATINO, a nine-year follow-up study of COPD in the city of São Paulo, Brazil: The problem of underdiagnosis;PLATINO, estudo de seguimento de nove anos sobre DPOC na cidade de São Paulo: O problema do subdiagnóstico

Jornal Brasileiro de Pneumologia

Volumn 40, Issue 1, 2014, Pages 30-37

  Moreira, Graciane Laender ^a   Manzano, Beatriz Martins ^a   Gazzotti, Mariana Rodrigues ^b   Nascimento, Oliver Augusto ^a   Perez Padilla, Rogelio ^c   Menezes, Ana Maria Baptista ^d   Jardim, José Roberto ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Sao Camilo University Center   (Brazil)

^c INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^d FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

Author keywords

Chronic obstructive epidemiology; Chronic obstructive diagnosis; Pulmonary disease; Spirometry

Indexed keywords

AGED; ARTICLE; BODY MASS; BRAZIL; CHRONIC OBSTRUCTIVE LUNG DISEASE; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; MALE; MIDDLE AGED; QUESTIONNAIRE; SOCIOECONOMICS; SPIROMETRY; URBAN POPULATION;

AGED; BODY MASS INDEX; BRAZIL; FEMALE; FOLLOW-UP STUDIES; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; SOCIOECONOMIC FACTORS; SPIROMETRY; URBAN POPULATION;

EID: 84896844878     PISSN: 18063713     EISSN: 18063756     Source Type: Journal    
DOI: 10.1590/S1806-37132014000100005     Document Type: Article

References (27)

1. Menezes AM, Victora CG, Perez-Padilla R; PLATINO Team. The Platino project: methodology of a multicenter prevalence survey of chronic obstructive pulmonary disease in major Latin American cities. BMC Med Res Methodol. 2004;4:15. http://dx.doi.org/10.1186/1471-2288-4-15 PMid:15202950 PMCid:PMC442126
2. Menezes AM, Jardim JR, Pérez-Padilla R, Camelier A, Rosa F, Nascimento O, Hallal PC. Prevalence of chronic obstructive pulmonary disease and associated factors: the PLATINO Study in São Paulo, Brazil. Cad Saude Publica. 2005;21(5):1565-73. http://dx.doi.org/10.1590/S0102-311X2005000500030 PMid:16158163
3. Menezes AM, Perez-Padilla R, Jardim JR, Mui-o A, Lopez MV, Valdivia G, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet. 2005;366(9500):1875-81. http://dx.doi.org/10.1016/S0140-6736(05)67632-5
4. Montes de Oca M, Tálamo C, Halbert RJ, Perez-Padilla R, Lopez MV, Mui-o A, et al. Health status perception and airflow obstruction in five Latin American cities: the PLATINO study. Respir Med. 2009;103(9):1376-82. http://dx.doi.org/10.1016/j.rmed.2009.03.005 PMid:19364640
5. Nascimento OA, Camelier A, Rosa FW, Menezes AM, Pérez-Padilla R, Jardim JR, et al. Chronic obstructive pulmonary disease is underdiagnosed and undertreated in São Paulo (Brazil): results of the PLATINO study. Braz J Med Biol Res. 2007;40(7):887-95. http://dx.doi.org/10.1590/S0100-879X2006005000133 PMid:17653440
6. Tálamo C, de Oca MM, Halbert R, Perez-Padilla R, Jardim JR, Mui-o A, et al. Diagnostic labeling of COPD in five Latin American cities. Chest. 2007;131(1):60-7. http://dx.doi.org/10.1378/chest.06-1149 PMid:17218557
7. Ferris BG. Epidemiology Standardization Project (American Thoracic Society). Am Rev Respir Dis. 1978;118(6 Pt 2):1-120. PMid:742764
8. European Community Respiratory Health Survey II Steering Committee. The European Community Respiratory Health Survey II. Eur Respir J. 2002;20(5):1071-9. http://dx.doi.org/10.1183/09031936.02.00046802 PMid:12449157
9. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319-38. http://dx.doi.org/10.1183/09031936.05.00034805 PMid:16055882
10. Global Initiative for Chronic Obstructive Lung Disease [homepage on the Internet]. Bethesda: Global Initiative for Chronic Obstructive Lung Disease. [cited 2013 Aug 20]. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. Updated 2013. [Adobe Acrobat document, 99p.]. Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2013_Feb20.pdf
11. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997;349(9064):1498-504. http://dx.doi.org/10.1016/S0140-6736(96)07492-2
12. Queiroz MC, Moreira MA, Rabahi MF. Underdiagnosis of COPD at primary health care clinics in the city of Aparecida de Goiânia, Brazil. J Bras Pneumol. 2012;38(6):692-9. http://dx.doi.org/10.1590/S1806-37132012000600003 PMid:23288113
13. Pe-a VS, Miravitlles M, Gabriel R, Jiménez-Ruiz CA, Villasante C, Masa JF, et al. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest. 2000;118(4):981-9. http://dx.doi.org/10.1378/chest.118.4.981
14. Coultas DB, Mapel D, Gagnon R, Lydick E. The health impact of undiagnosed airflow obstruction in a national sample of United States adults. Am J Respir Crit Care Med. 2001;164(3):372-7. http://dx.doi.org/10.1164/ajrccm.164.3.2004029 PMid:11500335
15. Miravitlles M, de la Roza C, Morera J, Montemayor T, Gobartt E, Martín A, et al. Chronic respiratory symptoms, spirometry and knowledge of COPD among general population. Respir Med. 2006;100(11):1973-80. http://dx.doi.org/10.1016/j.rmed.2006.02.024 PMid:16626950
16. Mannino DM. Defining chronic obstructive pulmonary disease. and the elephant in the room. Eur Respir J. 2007;30(2):189-90. http://dx.doi.org/10.1183/09031936.00058707 PMid:17666553
17. Schirnhofer L, Lamprecht B, Firlei N, Kaiser B, Buist AS, Halbert RJ, et al. Using targeted spirometry to reduce non-diagnosed chronic obstructive pulmonary disease. Respiration. 2011;81(6):476-82. http://dx.doi.org/10.1159/000320251 PMid:20720402
18. Minas M, Hatzoglou C, Karetsi E, Papaioannou AI, Tanou K, Tsaroucha R, et al. COPD prevalence and the differences between newly and previously diagnosed COPD patients in a spirometry program. Prim Care Respir J. 2010;19(4):363-70. http://dx.doi.org/10.4104/pcrj.2010.00034 PMid:20532466
19. Hill K, Goldstein RS, Guyatt GH, Blouin M, Tan WC, Davis LL, et al. Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care. CMAJ. 2010;182(7):673-8. http://dx.doi.org/10.1503/cmaj.091784 PMid:20371646 PMCid:PMC2855915
20. de Marco R, Accordini S, Marcon A, Cerveri I, Antó JM, Gislason T, et al. Risk factors for chronic obstructive pulmonary disease in a European cohort of young adults. Am J Respir Crit Care Med. 2011;183(7):891-7. http://dx.doi.org/10.1164/rccm.201007-1125OC PMid:20935112
21. Celli BR, Halbert RJ, Isonaka S, Schau B. Population impact of different definitions of airway obstruction. Eur Respir J. 2003;22(2):268-73. http://dx.doi.org/10.1183/09031936.03.00075102 PMid:12952259
22. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948-68. http://dx.doi.org/10.1183/09031936.05.00035205 PMid:16264058
23. Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society. Am Rev Respir Dis. 1991;144(5):1202-18. http://dx.doi.org/10.1164/ajrccm/144.5.1202 PMid:1952453
24. Lamprecht B, Schirnhofer L, Kaiser B, Buist SA, Mannino DM, Studnicka M. Subjects with Discordant Airways Obstruction: Lost between Spirometric Definitions of COPD. Pulm Med. 2011;2011:780215. doi: 10.1155/2011/780215
25. Celli BR, Halbert RJ. Point: should we abandon FEV1/FVC <0.70 to detect airway obstruction? No. Chest. 2010;138(5):1037-40. http://dx.doi.org/10.1378/chest.10-2049 PMid:21051393
26. Enright P, Brusasco V. Counterpoint: should we abandon FEV1/FVC < 0.70 to detect airway obstruction? Yes. Chest. 2010;138(5):1040-2; discussion 1042-4. http://dx.doi.org/10.1378/chest.10-2052 PMid:21051394
27. Perez-Padilla R, Wehrmeister FC, Celli BR, Lopez-Varela MV, Montes de Oca M, Mui-o A, et al. Reliability of FEV1/FEV6 to diagnose airflow obstruction compared with FEV1/FVC: the PLATINO longitudinal study. PLoS One. 2013;8(8):e67960. http://dx.doi.org/10.1371/journal.pone.0067960 PMid:23936297 PMCid:PMC3731337